Inspire Medical Systems board authorizes $200M share repurchase program

Inspire Medical Systems, Inc.

Board authorized repurchase of up to $200M of common stock.
Program expires August 7, 2027, unless extended or terminated earlier.
CEO cites financial strength and confidence in growth as rationale.
Company states stock is undervalued and addressable market lightly penetrated.
Purchases may occur via open market or private transactions; no obligation to buy specific number.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.